By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Liminatus Pharma, Inc. Warrants (LIMNW)

NASDAQ Currency in USD
$0.18
$0.00
-2.25%
Last Update: 11 Sept 2025, 20:00
$4.94M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.18 - $0.18
52 Week Range

LIMNW Stock Price Chart

Explore Liminatus Pharma, Inc. Warrants interactive price chart. Choose custom timeframes to analyze LIMNW price movements and trends.

LIMNW Company Profile

Discover essential business fundamentals and corporate details for Liminatus Pharma, Inc. Warrants (LIMNW) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

30 Apr 2025

Employees

CEO

Chris Kim

Description

Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.

LIMNW Financial Timeline

Browse a chronological timeline of Liminatus Pharma, Inc. Warrants corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

LIMNW Stock Performance

Access detailed LIMNW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run